NewsBenzinga强生公布其 ICOTYDE 治疗高影响力斑块型银屑病部位的 III 期 ICONIC-TOTAL 研究两年数据；112 周时，60% 的头皮银屑病患者和 89% 的生殖器银屑病患者实现了部位特异性皮肤完全清除 强生公布其 ICOTYDE 治疗高影响力斑块型银屑病部位的 III 期 ICONIC-TOTAL 研究两年数据；112 周时，60% 的头皮银屑病患者和 89% 的生殖器银屑病患者实现了部位特异性皮肤完全清除 Benzinga 2026.10.02 10:03 (GMT+0) Open on Benzinga Other news Roth Capital Maintains Buy on Sequans Communications, Lowers Price Target to $15 Stifel Maintains Hold on JB Hunt Transport Servs, Lowers Price Target to $289 QUICK SPARK: Trump Says US Will Not Attack Iran Before Midterm Election EXCLUSIVE: TSMC Plans Up to $64 Billion in Capex and Still Isn’t ‘Building Enough,’ Says Applied Materials Veteran Stifel Maintains Buy on Knight-Swift, Raises Price Target to $90 'Carlyle Says Deal to Buy Lukoil International Assets Has Expired'- Bloomberg
EXCLUSIVE: TSMC Plans Up to $64 Billion in Capex and Still Isn’t ‘Building Enough,’ Says Applied Materials Veteran
